Brief: BCAL To Acquire Shares In Genetic Signatures
02/07/2026 02:34
BRIEF-BCAL To Acquire Shares In Genetic Signatures July 2 (Reuters) - BCAL Diagnostics Ltd BDX.AX:
BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSS
TO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLION
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures